908 Devices Inc. (MASS)
NASDAQ: MASS · IEX Real-Time Price · USD
6.85
-0.03 (-0.44%)
At close: May 17, 2024, 4:00 PM
6.94
+0.09 (1.31%)
After-hours: May 17, 2024, 6:53 PM EDT
908 Devices Market Cap
908 Devices has a market cap or net worth of $235.19 million as of May 17, 2024. Its market cap has decreased by -3.01% in one year.
Market Cap
235.19M
Enterprise Value
106.45M
1-Year Change
-3.01%
Ranking
Category
Stock Price
$6.85
Market Cap Chart
Since the IPO on December 18, 2020, 908 Devices's market cap has decreased from $523.86M to $235.19M, a decrease of -55.11%. That is a compound annual growth rate of -20.91%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 17, 2024 | 236.20M | -0.46% |
| May 16, 2024 | 237.30M | -4.97% |
| May 15, 2024 | 249.70M | 1.26% |
| May 14, 2024 | 246.60M | 9.02% |
| May 13, 2024 | 226.20M | 15.06% |
| May 10, 2024 | 196.60M | -1.01% |
| May 9, 2024 | 198.60M | 1.02% |
| May 8, 2024 | 196.60M | - |
| May 7, 2024 | 196.60M | 1.44% |
| May 6, 2024 | 193.80M | -0.51% |
| May 3, 2024 | 194.80M | 4.39% |
| May 2, 2024 | 186.60M | -0.16% |
| May 1, 2024 | 186.90M | -0.37% |
| Apr 30, 2024 | 187.60M | -0.95% |
| Apr 29, 2024 | 189.40M | 1.50% |
| Apr 26, 2024 | 186.60M | 1.97% |
| Apr 25, 2024 | 183.00M | -1.08% |
| Apr 24, 2024 | 185.00M | 1.09% |
| Apr 23, 2024 | 183.00M | -0.54% |
| Apr 22, 2024 | 184.00M | 0.22% |
| Apr 19, 2024 | 183.60M | -0.38% |
| Apr 18, 2024 | 184.30M | 0.16% |
| Apr 17, 2024 | 184.00M | -3.41% |
| Apr 16, 2024 | 190.50M | - |
| Apr 15, 2024 | 190.50M | -4.65% |
View and export this data all the way back to 2020.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| uniQure | 245.66M |
| AirSculpt Technologies | 244.67M |
| G1 Therapeutics | 243.89M |
| Aldeyra Therapeutics | 243.01M |
| Akebia Therapeutics | 237.89M |
| OptimizeRx | 234.03M |
| Ovid Therapeutics | 232.26M |
| Prelude Therapeutics | 229.61M |